- Home
- AMBA vs ACAD Comparison
AMBA vs ACAD Comparison
Compare AMBA & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBA
- ACAD
- Stock Information
- Founded
- AMBA 2004
- ACAD 1993
- Country
- AMBA United States
- ACAD United States
- Employees
- AMBA N/A
- ACAD N/A
- Industry
- AMBA Semiconductors
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- AMBA Technology
- ACAD Health Care
- Exchange
- AMBA Nasdaq
- ACAD Nasdaq
- Market Cap
- AMBA 2.3B
- ACAD 2.6B
- IPO Year
- AMBA N/A
- ACAD 2004
- Fundamental
- Price
- AMBA $63.62
- ACAD $16.37
- Analyst Decision
- AMBA Buy
- ACAD Buy
- Analyst Count
- AMBA 11
- ACAD 19
- Target Price
- AMBA $74.09
- ACAD $26.44
- AVG Volume (30 Days)
- AMBA 337.4K
- ACAD 1.5M
- Earning Date
- AMBA 11-26-2024
- ACAD 11-06-2024
- Dividend Yield
- AMBA N/A
- ACAD N/A
- EPS Growth
- AMBA N/A
- ACAD N/A
- EPS
- AMBA N/A
- ACAD 0.78
- Revenue
- AMBA $220,408,000.00
- ACAD $929,236,000.00
- Revenue This Year
- AMBA $20.11
- ACAD $35.78
- Revenue Next Year
- AMBA $19.21
- ACAD $8.58
- P/E Ratio
- AMBA N/A
- ACAD $21.09
- Revenue Growth
- AMBA N/A
- ACAD 47.06
- 52 Week Low
- AMBA $39.69
- ACAD $14.15
- 52 Week High
- AMBA $65.88
- ACAD $32.59
- Technical
- Relative Strength Index (RSI)
- AMBA 64.29
- ACAD 52.86
- Support Level
- AMBA $56.40
- ACAD $15.66
- Resistance Level
- AMBA $59.25
- ACAD $18.71
- Average True Range (ATR)
- AMBA 2.10
- ACAD 0.78
- MACD
- AMBA 0.22
- ACAD -0.07
- Stochastic Oscillator
- AMBA 97.36
- ACAD 45.58
About AMBA Ambarella Inc.
Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, and security cameras. Ambarella's system-on-a-chip designs, based on its proprietary technology platform, are highly configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.